Amgen Announces $1B Holly Springs Factory Expansion
Amgen announced a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina. This brings the company’s total planned investment in Holly Springs to more than $1.5 billion, building on its previously announced $550 million commitment. The $1 billion facility will incorporate cutting-edge…
